Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 9;39(8):1042-1044.
doi: 10.1016/j.ccell.2021.06.019. Epub 2021 Jul 1.

Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic

Chris Labaki  1 , Ziad Bakouny  2 , Andrew Schmidt  1 , Stuart R Lipsitz  3 , Timothy R Rebbeck  4 , Quoc-Dien Trinh  5 , Toni K Choueiri  6
Affiliations

Recovery of cancer screening tests and possible associated disparities after the first peak of the COVID-19 pandemic

Chris Labaki et al. Cancer Cell. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of interests Z.B. reports receiving grants from Genentech/IMCore, nonfinancial support from Bristol Myers Squibb, and honoraria from UpToDate outside this work. A.S. reports receiving nonfinancial support from Astellas and Pfizer outside this work. Q.D.T. reports receiving personal fees from Astellas, Bayer, and Janssen and grants from Intuitive Surgical outside this work. T.K.C. is a member of the steering committee of the COVID-19 and Cancer Consortium (CCC19) and ESMO-CoCARE registries and reports personal fees from AstraZeneca, Aveo, Bayer, Bristol Myers-Squibb, Eisai, EMD Serono, Exelixis, GlaxoSmithKline, IQVA, Ipsen, Kanaph, Lilly, Merck, Nikang, Novartis, Pfizer, Roche, Sanofi/Aventis, Takeda, Tempest, Up-To-Date, and CME events (Peerview, OncLive, and others) related to kidney cancer for clinical trials, being on advisory boards, consultancy, and manuscript support outside this work. T.K.C. is also supported in part by the Dana-Farber/Harvard Cancer Center Kidney SPORE and Program, the Kohlberg Chair at Harvard Medical School, and the Trust Family, Michael Brigham, and Loker Pinard Funds for Kidney Cancer Research at DFCI. No other disclosures are reported.

References

    1. Bakouny Z., Paciotti M., Schmidt A.L., Lipsitz S.R., Choueiri T.K., Trinh Q.D. Cancer Screening Tests and Cancer Diagnoses During the COVID-19 Pandemic. JAMA Oncol. 2021;7:458–460. - PMC - PubMed
    1. Chen R.C., Haynes K., Du S., Barron J., Katz A.J. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic. JAMA Oncol. 2021;7:878–884. - PMC - PubMed
    1. Hartman H.E., Sun Y., Devasia T.P., Chase E.C., Jairath N.K., Dess R.T., Jackson W.C., Morris E., Li P., Hochstedler K.A., et al. Integrated Survival Estimates for Cancer Treatment Delay Among Adults With Cancer During the COVID-19 Pandemic. JAMA Oncol. 2020;6:1881–1889. - PMC - PubMed
    1. Issaka R.B., Somsouk M. Colorectal Cancer Screening and Prevention in the COVID-19 Era. JAMA Heal. Forum. 2020;1 - PMC - PubMed
    1. Kind A.J.H., Buckingham W.R. Making Neighborhood-Disadvantage Metrics Accessible - The Neighborhood Atlas. N. Engl. J. Med. 2018;378:2456–2458. - PMC - PubMed